| Metric | Q4 2024 | Q3 2024 | Q4 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $111M | — | $91M | — | 21.9% |
| Op. Income | $35M | — | $26M | — | 34.6% |
| Gross Margin | 68.0% | — | 76.5% | — | -8.5pp |
| Net Margin | 24.7% | — | 21.0% | — | 3.7pp |
| EPS (Diluted) | $0.18 | — | $0.13 | — | 38.5% |
| Free Cash Flow | $34M | — | $35M | — | -3.0% |
| Item | Amount |
|---|---|
| REVENUE | $111M |
| Cost of Revenue | $35M |
| GROSS PROFIT | $75M |
| R&D Expenses | $0 |
| Selling & Marketing | $10M |
| General & Administrative | $6M |
| SG&A Expenses | $16M |
| Other Expenses | $24M |
| Operating Expenses | $40M |
| Cost & Expenses | $76M |
| OPERATING INCOME | $35M |
| Interest Income | $2M |
| Interest Expense | $6M |
| Other Income/Expenses | -$842.0K |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $832.0K |
| EBIT | $35M |
| EBITDA | $36M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $111M |
| Cost of Revenue | $35M |
| GROSS PROFIT | $75M |
| R&D Expenses | $0 |
| Selling & Marketing | $10M |
| General & Administrative | $6M |
| SG&A Expenses | $16M |
| Other Expenses | $24M |
| Operating Expenses | $40M |
| Cost & Expenses | $76M |
| OPERATING INCOME | $35M |
| Interest Income | $2M |
| Interest Expense | $6M |
| Other Income/Expenses | -$842.0K |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $832.0K |
| EBIT | $35M |
| EBITDA | $36M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $27M |
| Depreciation & Amortization | $832.0K |
| Stock-Based Compensation | $5M |
| Deferred Income Tax | -$3M |
| Other Non-Cash Items | -$15M |
| Change in Working Capital | $19M |
| OPERATING CASH FLOW | $35M |
| Capital Expenditure | -$559.0K |
| Acquisitions (Net) | $100.0K |
| Purchases of Investments | -$12M |
| Sales/Maturities of Investments | $6M |
| Other Investing Activities | -$546.0K |
| NET CASH FROM INVESTING | -$7M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$4M |
| Other Financing Activities | -$15M |
| NET CASH FROM FINANCING | -$19M |
| FREE CASH FLOW | $34M |
| Net Change in Cash | $5M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $181M |
| Short-Term Investments | $85M |
| Net Receivables | $45M |
| Inventory | $0 |
| Other Current Assets | $2M |
| TOTAL CURRENT ASSETS | $318M |
| PP&E (Net) | $1M |
| Goodwill | $87M |
| Intangible Assets | $606M |
| Long-Term Investments | $9M |
| Tax Assets | $12M |
| Other Non-Current Assets | $425.0K |
| TOTAL NON-CURRENT ASSETS | $715M |
| TOTAL ASSETS | $1.0B |
| Account Payables | $22M |
| Short-Term Debt | $709.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$709.0K |
| TOTAL CURRENT LIABILITIES | $109M |
| Long-Term Debt | $512M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $509.0K |
| Other Non-Current Liabilities | $12M |
| TOTAL NON-CURRENT LIABILITIES | $524M |
| TOTAL LIABILITIES | $634M |
| Common Stock | $1M |
| Additional Paid-In Capital | $270M |
| Retained Earnings | $130M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $400M |
| Minority Interest | $0 |
| TOTAL EQUITY | $400M |
| TOTAL LIABILITIES & EQUITY | $1.0B |
| Total Debt | $513M |
| Net Debt | $332M |
